Known targets — ChEMBL curated mechanism
ABL1ACEACHEACVR1ADRA1AADRA1BADRA1DADRA2AADRA2BADRA2CADRB1ADRB2ADRB3AGTR1ALKAVPR1AAVPR2BCHEBCRCA2CACNA1ACACNA1BCACNA1CCACNA1DCACNA1ECACNA1FCACNA1GCACNA1HCACNA1ICACNA1SCACNA2D1CACNA2D2CACNA2D3CACNA2D4CACNB1CACNB2CACNB3CACNB4CACNG1CACNG2CACNG3CACNG4CACNG5CACNG6CACNG7CACNG8CALCRLCASRCCR5CDK4CDK6CFBCHRM1CHRM2CHRM3CHRM4CHRM5CHRNA1CHRNA3CHRNA7CHRNB1CHRNB4CHRNDCHRNECHRNGCOXFA4COXFA4L2CRBNCSF1RCUL4ACYP19A1DDB1DPP4DRD1DRD2DRD3DRD4EDNRAEGFREML4ERBB2ERBB4ESR1ESR2FGFR1FGFR3FLT1FLT3FLT4GAAGABRA1GABRA2GABRA3GABRA4GABRA5GABRA6GABRB1GABRB2GABRB3GABRDGABREGABRG1GABRG2GABRG3GABRPGABRQGHSRGLAGNRHRGPD2GRIN1GRIN2AGRIN2BGRIN2CGRIN2DGRIN3AGRIN3BGSTP1HCN4HCRTR1HCRTR2HDAC1HDAC10HDAC11HDAC2HDAC3HDAC4HDAC5HDAC6HDAC7HDAC8HDAC9HRH1HRH2HRH3HSD11B1HSP90AA1HSP90AB1HTR1AHTR1BHTR1DHTR1EHTR1FHTR2AHTR2BHTR2CHTR3AHTR3BHTR3CHTR3DHTR3EHTR4HTR5AHTR6HTR7IMPDH1IMPDH2ITGA2BITGB3ITKJAK1JAK2KCNA1KCNA10KCNA2KCNA3KCNA4KCNA5KCNA6KCNA7KCNB1KCNB2KCNC1KCNC2KCNC3KCNC4KCND1KCND2KCND3KCNF1KCNG1KCNG2KCNG3KCNG4KCNH1KCNH2KCNH3KCNH4KCNH5KCNH6KCNH7KCNH8KCNJ2KCNJ3KCNJ5KCNK3KCNK9KCNQ1KCNQ2KCNQ3KCNQ4KCNQ5KCNS1KCNS2KCNS3KCNV1KCNV2KDRKITKLKB1LCKMMAOAMAOBMAPK14METMMP1MMP13MMP7MMP8MT-ND1MT-ND2MT-ND3MT-ND4MT-ND4LMT-ND5MT-ND6NDUFA1NDUFA10NDUFA11NDUFA12NDUFA13NDUFA2NDUFA3NDUFA5NDUFA6NDUFA7NDUFA8NDUFA9NDUFAB1NDUFAF1NDUFAF2NDUFAF3NDUFAF4NDUFB1NDUFB10NDUFB11NDUFB2NDUFB3NDUFB4NDUFB5NDUFB6NDUFB7NDUFB8NDUFB9NDUFC1NDUFC2NDUFS1NDUFS2NDUFS3NDUFS4NDUFS5NDUFS6NDUFS7NDUFS8NDUFV1NDUFV2NDUFV3NR3C1NS5ANTRK1NTRK2NTRK3ODC1OPRD1OPRK1OPRM1P2RY12PAHPARP1PDE3APDE3BPDE4APDE4BPDE4CPDE4DPDE5APDE7APDE7BPDE8APDE8BPDGFRAPDGFRBPIK3CAPIK3CDPNPPOLA1POLA2POLD1POLD2POLD3POLD4POLEPOLE2POLE3PPARGPRIM1PRIM2PRKCAPRKCBPRKCDPRKCEPRKCGPRKCHPRKCIPRKCQPRKCZPRKD1PRKD3PTGS1PTGS2RBX1RENRETROCK1ROCK2RPE65RRM1RRM2RRM2BS1PR1S1PR2S1PR3S1PR4S1PR5SCN10ASCN11ASCN1ASCN2ASCN3ASCN4ASCN5ASCN7ASCN8ASCN9ASCNN1ASCNN1BSCNN1GSIGMAR1SLC18A2SLC6A1SLC6A2SLC6A3SLC6A4SLC9A3SRCTACR1TOP1TOP2ATOP2BTTRTYMPdacAdacBdacCembAfolAftsIgyrAgyrBmrcAmrcBmrdAparCparEpolrplArplBrplCrplDrplErplFrplIrplJrplKrplLrplMrplNrplOrplPrplQrplRrplSrplTrplUrplVrplWrplXrplYrpmArpmBrpmCrpmDrpmErpmE2rpmFrpmGrpmG1rpmG2rpmG3rpmHrpmIrpmJrpsArpsBrpsCrpsDrpsErpsFrpsGrpsHrpsIrpsJrpsKrpsLrpsMrpsNrpsOrpsPrpsQrpsRrpsSrpsTrpsUykgMykgO
The experimentally established mechanism targets of Hydrochloric Acid. The predicted profile below is derived independently by chemical similarity — agreement is a validation signal, a miss is honest.
Predicted protein targets (top 6)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | TOP1 known ✓ | P11387 | 4/20 | 0.60 |
| ▸ | STAT3 | P40763 | 1/20 | 0.59 |
| ▸ | STAT1 | P42224 | 1/20 | 0.59 |
| ▸ | CYCS | P99999 | 3/20 | 0.58 |
| ▸ | TERT | O14746 | 4/20 | 0.57 |
| ▸ | ENPP2 | Q13822 | 1/20 | 0.53 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL3212598 | 0.98 | TOP1 (0.62) | TOP1STAT3STAT1CYCSTERT | |
| Hydrochloric Acid SCHEMBL31677406 | 0.98 | TOP1 (0.62) | TOP1STAT3STAT1CYCSTERT | |
| Hydrochloric Acid SCHEMBL7157353 | 0.96 | TOP1 (0.60) | TOP1STAT3STAT1CYCSTERT | |
| Hydrochloric Acid SCHEMBL5572880 | 0.96 | TOP1 (0.60) | TOP1STAT3STAT1CYCSTERT | |
| Hydrochloric Acid SCHEMBL1304945 | 0.96 | TOP1 (0.60) | TOP1STAT3STAT1CYCSTERT | |
| Hydrochloric Acid SCHEMBL483549 | 0.96 | TOP1 (0.60) | TOP1STAT3STAT1CYCSTERT | |
| Hydrochloric Acid SCHEMBL483748 | 0.96 | TOP1 (0.60) | TOP1STAT3STAT1CYCSTERT | |
| Hydrochloric Acid SCHEMBL599424 | 0.96 | TOP1 (0.60) | TOP1STAT3STAT1CYCSTERT | |
| Hydrochloric Acid SCHEMBL483503 | 0.96 | TOP1 (0.60) | TOP1STAT3STAT1CYCSTERT | |
| SCHEMBL29405434 | 0.96 | TOP1 (0.64) | TOP1STAT3STAT1CYCSTERT |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 70 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| CN-106290631-B | A kind of method of pigment array sensing technology Fast Evaluation magma Quality of Liquors | 江苏今世缘酒业股份有限公司 | 2018-11-27 | — | — | CN | claimed |
| CN-106290631-A | A kind of method of pigment array sensing technology Fast Evaluation original plasm wine quality | 江苏今世缘酒业股份有限公司 | 2017-01-04 | — | — | CN | claimed |
| US-7297657-B2 | Process for the preparation of N-(phosphonomethyl)glycine by oxidizing N-substituted N-(phosphonomethyl)glycine | MONSANTO TECHNOLOGY LLC (US) | 2007-11-20 | — | — | US | claimed |
| EP-1716923-A1 | Oxidation catalyst for making glyphosate | Monsanto Technology, LLC (US) | 2006-11-02 | — | — | EP | claimed |
| EP-1062221-B1 | PROCESS FOR MAKING GLYPHOSATE BY OXIDIZING N-SUBSTITUTED GLYPHOSATES | MONSANTO TECHNOLOGY LLC (US) | 2006-05-10 | — | — | EP | claimed |
| EP-1104427-B1 | PROCESS FOR THE PREPARATION OF N-(PHOSPHONOMETHYL)GLYCINE BY OXIDIZING N-SUBSTITUTED N-(PHOSPHONOMETHYL)GLYCINE | MONSANTO TECHNOLOGY LLC (US) | 2005-03-09 | — | — | EP | claimed |
| US-20040143134-A1 | Process for the preparation of N-(phosphonomethyl)glycine by oxidizing N-substituted N-(phosphonomethyl)glycine | MONSANTO TECHNOLOGY LLC | 2004-07-22 | — | — | US | claimed |
| JP-2002510305-A | — | — | 2002-04-02 | — | — | JP | claimed |
| EP-1062221-A4 | PROCESS FOR MAKING GLYPHOSATE BY OXIDIZING N-SUBSTITUTED GLYPHOSATES | MONSANTO TECHNOLOGY LLC (US) | 2001-10-17 | — | — | EP | claimed |
| US-20010018536-A1 | Process for the preparation of n- (phosphonomethyl) glycine by oxidizing n-substituted n-(phosphonomethyl) glycine | MONSANTO TECHNOLOGY LLC | 2001-08-30 | — | — | US | claimed |
| US-6232494-B1 | CATALYTIC OXIDATION | MONSANTO COMPANY | 2001-05-15 | — | — | US | claimed |
| EP-1062221-A1 | PROCESS FOR MAKING GLYPHOSATE BY OXIDIZING N-SUBSTITUTED GLYPHOSATES | MONSANTO COMPANY (US) | 2000-12-27 | — | — | EP | claimed |
| US-6005140-A | USING A NOBLE METAL OXIDATION CATALYST | MONSANTO COMPANY (US) | 1999-12-21 | — | — | US | claimed |
| WO-1999041260-A1 | PROCESS FOR MAKING GLYPHOSATE BY OXIDIZING N-SUBSTITUTED GLYPHOSATES | MONSANTO COMPANY (US) | 1999-08-19 | — | — | WO | claimed |
| US-20240327576-A1 | METHOD FOR MANUFACTURING SULFUR-CONTAINING POLYMER | NIPPON SHOKUBAI CO., LTD. (JP) | 2024-10-03 | — | — | US | disclosed |
| EP-4361200-A1 | METHOD FOR MANUFACTURING SULFUR-CONTAINING POLYMER | Nippon Shokubai Co., Ltd. (JP) | 2024-05-01 | — | — | EP | disclosed |
| WO-2022270533-A1 | METHOD FOR MANUFACTURING SULFUR-CONTAINING POLYMER | 株式会社日本触媒 | 2022-12-29 | — | — | WO | disclosed |
| EP-0308101-B1 | PREPARATION OF TERTIARY BUTYL ALCOHOL | TEXACO DEVELOPMENT CORPORATION (US) | 1992-07-22 | — | — | EP | disclosed |
| US-4922034-A | Catalyzed conversion of tertiary butyl hydroperoxide to tertiary butyl alcohol | TEXACO INC. (US) | 1990-05-01 | — | — | US | disclosed |
| EP-0308101-A1 | Preparation of tertiary butyl alcohol | TEXACO DEVELOPMENT CORPORATION (US) | 1989-03-22 | — | — | EP | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20010018536-A1 | Process for the preparation of n- (phosphonomethyl) glycine by oxidizing n-substituted n-(phosphonomethyl) glycine | GNMT, GRHPR, GLRA3 | TOP1 3870/4885STAT3 2155/4885STAT1 1351/4885 |
| US-20040143134-A1 | Process for the preparation of N-(phosphonomethyl)glycine by oxidizing N-substituted N-(phosphonomethyl)glycine | GNMT, GRHPR, GLRA3 | TOP1 3845/4885STAT3 2240/4885STAT1 1369/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.